Panacea Biotec Limited Faces Setback in Tax Litigation
Panacea Biotec Limited announced on March 27, 2026, that the Commissioner of Income Tax (Appeals) in New Delhi dismissed appeals filed by the company concerning penalty orders issued on December 24, 2025. The Assistant Commissioner of Income Tax, New Delhi, had imposed penalties related to alleged underreporting of income, resulting in a demand of approximately ₹9.38 crore for the assessment years 2017-18, 2020-21, and 2021-22.The company assesses that the demand is not maintainable and stated it will pursue further appeals with appellate authorities. Panacea Biotec does not anticipate a material impact on its financial, operational, or other activities as a result of this development.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.